Dong Lin

Title: The Innovations of Dong Lin in Genetic Research

Introduction

Dong Lin is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of genetic research, particularly in understanding congenital lipoid adrenal hyperplasia. His work has implications for diagnosing genetic disorders and advancing medical science.

Latest Patents

Dong Lin holds a patent for the "Identification of gene mutations associated with congenital lipoid." This patent outlines a method for diagnosing congenital lipoid adrenal hyperplasia and detecting the presence of a mutated gene for steroidogenesis acute regulatory protein (StAR) by analyzing nucleic acid obtained from a patient. The nucleic acid can be analyzed using various techniques, including restriction fragment length polymorphism analysis, nucleic acid hybridization, or nucleotide sequencing. A mutation may lead to premature termination of the protein, affect the transcription or translation of the StAR gene, or alter the amino acid sequence of the StAR gene product. He has 1 patent to his name.

Career Highlights

Dong Lin is affiliated with the University of California, where he conducts his research. His work has been instrumental in advancing the understanding of genetic mutations and their implications for human health.

Collaborations

He has collaborated with notable colleagues, including Walter L. Miller and Jerome F. Strauss, who have also contributed to the field of genetic research.

Conclusion

Dong Lin's innovative work in genetic research highlights the importance of understanding gene mutations and their impact on health. His contributions continue to pave the way for advancements in medical diagnostics and treatment.